I connected with them through 21.co and spoke with one of the co-founders and they seem to have a great platform and partnerships. Essentially their token will become the price of patient data by pharmaceutical companies. They do not seem to be a typical [Suspicious link removed]pany, as they are very good at the business side (large partnerships in place), but are not on top of the top channels for reaching ICO investors. They are offering deals to larger investor groups, and we are putting a buying group together for their token (50% discount to the listed price). Comment or message if you would like more information.

We actually created an interactive version of their whitepaper as well and would love to have you and the other members of the thread join our discussion: http://mattervest.com/evermarkets

If you need some help finding material to promote, every section of our interactive whitepaper is shareable and includes a discussion board: http://mattervest.com/evermarkets